Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The Cleveland Clinic
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
This study is a substudy and subjects must be enrolled in the main trial:
See Study Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) In clinical trials. (clinical Trial ID NCT01179737)
http://clinicaltrials.gov/ct2/show/NCT01179737?
You may not be if
Subjects are not enrolled in the main study:
See Study Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) In clinical trials. (clinical Trial ID NCT01179737)
